D68.32
Hemorrhagic disorder due to extrinsic circulating anticoagulants
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T45.515, T45.525)
Inclusion Terms
- Drug-induced hemorrhagic disorder
- Hemorrhagic disorder due to increase in anti-IIa
- Hemorrhagic disorder due to increase in anti-Xa
- Hyperheparinemia
Medical Intelligence & Overview
Hemorrhagic disorder due to extrinsic circulating anticoagulants is a condition characterized by abnormal bleeding caused by the presence of substances in the blood that interfere with normal blood clotting. This particular disorder is often linked to medications that act as anticoagulants or blood thinners. It is classified under ICD-10 code D68.32 and is sometimes referred to as drug-induced hemorrhagic disorder, especially in the context of increased activity of anticoagulants such as anti-IIa or anti-Xa agents. Understanding this condition helps in managing and recognizing the risks associated with anticoagulant therapies.
Causes & Symptoms
Clinical Causes: Use of anticoagulant medications, particularly those that inhibit thrombin (anti-IIa) or factor Xa (anti-Xa) Hyperheparinemia, which is an excess of heparin in the blood due to overdose or impaired clearance Inappropriate dosing or prolonged use of anticoagulants Certain medical conditions that increase sensitivity to anticoagulants Drug interactions that enhance anticoagulant effects
Key Symptoms: Unusual or prolonged bleeding from cuts or injuries Bleeding gums Blood in urine or stool Unexplained bruising or large easy bruising Nosebleeds that are difficult to stop Swelling or pain at sites of bleeding In rare cases, internal bleeding affecting organs or joints
Diagnostic & Treatment
Diagnosis Path: Complete blood count (CBC) to assess blood cell counts Coagulation profile, including prothrombin time (PT), activated partial thromboplastin time (aPTT), and specific assays for anti-IIa and anti-Xa activity Tests to measure levels of anticoagulants such as heparin
Treatment Protocols: Ceasing or adjusting the dose of anticoagulant medications Administration of specific reversal agents, such as protamine sulfate for heparin Supportive care, including transfusions of blood products like fresh frozen plasma or platelets in severe cases Monitoring coagulation status regularly to guide ongoing treatment Addressing the underlying cause, such as drug overdose or therapy adjustment
Clinical Advice & FAQs
Billing Guidance
Is D68.32 a billable ICD-10 code?
Yes, D68.32 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D68.32?
Clinical documentation must specify the nature of Hemorrhagic disorder due to extrinsic circulating anticoagulants and any associated comorbidities for accurate reporting.
Cite this Clinical Reference